BRIEF published on 12/16/2025 at 09:58, 6 months 12 days ago Virbac acquiert Thyronorm pour lutter contre l'hyperthyroïdie féline Santé Animale Médecine Vétérinaire VIRBAC Hyperthyroïdie Féline Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 6 months 12 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
PRESS RELEASE published on 12/16/2025 at 09:53, 6 months 12 days ago VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Virbac acquiert Thyronorm pour traiter l'hyperthyroïdie féline, améliorant la qualité de vie des chats âgés. L'acquisition renforce le portefeuille produits de Virbac Acquisition VIRBAC Hyperthyroïdie Féline Thyronorm Chats Âgés
BRIEF published on 11/07/2025 at 15:44, 7 months 20 days ago Virbac : Mise à jour sur les actions et droits de vote Euronext Paris Droits De Vote Actions Transparence VIRBAC
BRIEF published on 11/07/2025 at 15:44, 7 months 20 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
PRESS RELEASE published on 11/07/2025 at 15:39, 7 months 20 days ago Virbac : Déclaration d'actions et de droits de vote 10/2025 Déclaration du nombre total d’actions et de droits de vote pour VIRBAC sur Euronext Paris. Total brut de droits de vote : 12 704 809, total net : 12 691 973 Euronext Paris Droits De Vote Santé Animale VIRBAC Total Actions
BRIEF published on 09/12/2025 at 17:50, 9 months 15 days ago Virbac Reports Solid Growth in 2025 First Half Results Revenue Growth Operating Income VIRBAC 2025 Forecast Global Market Performance
BRIEF published on 09/12/2025 at 17:50, 9 months 15 days ago Virbac annonce une croissance solide de ses résultats au premier semestre 2025 Croissance Des Revenus Résultat D'exploitation VIRBAC Prévisions Pour 2025 Performance Du Marché Mondial
PRESS RELEASE published on 09/12/2025 at 17:45, 9 months 15 days ago Virbac: 2025 Half-year results Virbac reports solid revenue growth of 5.6% in the first half of 2025, meeting adjusted operating income expectations. Targets for 2025 confirmed with revenue growth of 4-6% expected Financial Results Revenue Growth Operating Income VIRBAC Targets Confirmed
BRIEF published on 08/18/2025 at 09:35, 10 months 10 days ago Virbac dévoile la rémunération de son nouveau directeur général Directeur Général Remuneration Actions Gratuites VIRBAC Paul Martingell
Published on 06/27/2026 at 16:50, 22 hours 18 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 13 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 16 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 16 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 15 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 15 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 15 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 15 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 15 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
